Episode Description
This episode delivers an in-depth look at significant regulatory updates spanning OFAC enforcement activities, Labuan FSA’s strengthened compliance oversight, and ongoing collaboration with the Labuan International Business Association (LIBA). Additionally, it touches on medical regulatory considerations affecting Generalised Myasthenia Gravis treatments and antitrust developments within ASEAN.
The Labuan Financial Services Authority highlighted recent enforcement measures at the 2nd Labuan International Compliance Conference, stressing the importance of compliance with Anti-Money Laundering and Counter Financing of Terrorism requirements. Financial institutions are reminded to uphold capital standards, timely reporting, and appoint empowered compliance officers.
In Malaysia, the Securities Commission updated its Investor Alert List, cautioning against fraudulent market actors. Meanwhile, the Labuan FSA and LIBA members convened to discuss industry challenges and cooperation opportunities. On the international front, Republic Power Group Limited filed an updated prospectus with the U.S. SEC, ensuring transparency and regulatory compliance.
For more information, visit the Carver Agents website.
Articles mentioned:
- Opening Remarks by Mr Syahrul Imran Mahadzir, Deputy Director-General of Labuan FSA at The 2nd Labuan International Compliance Conference 2026
- Understanding selection criteria for medical device application audits
- Joint Statement from Australia-Philippines Defence Ministers' Meeting
- Summary report – RYSTIGGO®
- Treasury Dismantles Iranian Regime’s Global Clandestine Currency Networks
- Counter Terrorism and Iran-related Designations; Counter Narcotics Designations Removals; Issuance of Amended Iran-related Frequently Asked Question
- Attorney General Bonta Announces $400 Million Settlement in Principle with Sandoz
- Investor Alert List (as at 3/8/2026)
- 2026-08-04 - Prospectus [Rule 424(b)(4)] - Republic Power Group Ltd (0001912884)
- Dialogue Session Between Labuan FSA and LIBA Members (1/2026)